Option Care Health, Inc. (OPCH)
USD 32.23
(-0.14%)
USD 32.23
(-0.14%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 376.79 Million USD | 15.93% |
| 2022 | 345.81 Million USD | 28.82% |
| 2021 | 255.93 Million USD | 39.84% |
| 2020 | 182.65 Million USD | 237.88% |
| 2019 | 72.78 Million USD | 30.37% |
| 2018 | 79.32 Million USD | -38.65% |
| 2017 | 12.36 Million USD | 19.9% |
| 2016 | 25.44 Million USD | 6.29% |
| 2015 | -261.18 Million USD | 39.18% |
| 2014 | -70.32 Million USD | -28.07% |
| 2013 | -2.64 Million USD | 6.84% |
| 2012 | 25.75 Million USD | -31.15% |
| 2011 | 53.37 Million USD | 143.86% |
| 2010 | 18.56 Million USD | 88.64% |
| 2009 | 20.49 Million USD | -7.71% |
| 2008 | -77.12 Million USD | 5.13% |
| 2007 | 15.94 Million USD | 402.43% |
| 2006 | -5.38 Million USD | -150.43% |
| 2005 | 15.92 Million USD | -39.65% |
| 2004 | 17.31 Million USD | -17.95% |
| 2003 | 21.1 Million USD | -28.12% |
| 2002 | 30.21 Million USD | 53.95% |
| 2001 | 21.54 Million USD | 172.57% |
| 2000 | 4.69 Million USD | -26.11% |
| 1999 | -1.57 Million USD | -5.31% |
| 1998 | 7.97 Million USD | 158.82% |
| 1997 | -14.7 Million USD | 49.55% |
| 1996 | -32.3 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 96.17 Million USD | 14.04% |
| 2024 Q1 | 85.46 Million USD | -15.94% |
| 2024 Q3 | 101.12 Million USD | 8.33% |
| 2023 FY | - USD | 15.93% |
| 2023 Q1 | 83.28 Million USD | -11.51% |
| 2023 Q2 | 184.27 Million USD | 121.25% |
| 2023 Q3 | 96.66 Million USD | -47.54% |
| 2023 Q4 | 100.33 Million USD | 3.79% |
| 2022 Q3 | 82.55 Million USD | 6.28% |
| 2022 Q4 | 94.11 Million USD | 14.01% |
| 2022 Q1 | 69.49 Million USD | -8.44% |
| 2022 Q2 | 77.67 Million USD | 11.77% |
| 2022 FY | - USD | 28.82% |
| 2021 Q3 | 71.67 Million USD | 5.76% |
| 2021 Q4 | 75.9 Million USD | 5.89% |
| 2021 Q1 | 35.61 Million USD | -40.56% |
| 2021 FY | - USD | 39.84% |
| 2021 Q2 | 67.77 Million USD | 90.3% |
| 2020 Q3 | 43.59 Million USD | -1.37% |
| 2020 Q1 | 31.06 Million USD | -7.73% |
| 2020 Q2 | 44.2 Million USD | 42.31% |
| 2020 Q4 | 59.91 Million USD | 37.42% |
| 2020 FY | - USD | 237.88% |
| 2019 Q1 | 7.39 Million USD | -29.57% |
| 2019 Q4 | 33.66 Million USD | 270.17% |
| 2019 Q3 | 9.09 Million USD | -41.23% |
| 2019 Q2 | 15.47 Million USD | 109.21% |
| 2019 FY | - USD | 30.37% |
| 2018 Q4 | 10.5 Million USD | -40.66% |
| 2018 Q2 | 15.24 Million USD | 373.59% |
| 2018 Q1 | 3.21 Million USD | -84.03% |
| 2018 FY | - USD | -38.65% |
| 2018 Q3 | 17.69 Million USD | 16.12% |
| 2017 FY | - USD | 19.9% |
| 2017 Q2 | 15.79 Million USD | 34.49% |
| 2017 Q3 | 19.06 Million USD | 20.68% |
| 2017 Q4 | 20.15 Million USD | 5.71% |
| 2017 Q1 | 11.74 Million USD | -35.19% |
| 2016 FY | - USD | 6.29% |
| 2016 Q3 | 9.9 Million USD | -29.88% |
| 2016 Q2 | 14.13 Million USD | 4.5% |
| 2016 Q1 | 13.52 Million USD | -17.48% |
| 2016 Q4 | 18.12 Million USD | 82.94% |
| 2015 Q2 | 9.11 Million USD | -27.32% |
| 2015 Q3 | 12.9 Million USD | 41.63% |
| 2015 Q4 | 16.38 Million USD | 26.98% |
| 2015 FY | - USD | 39.18% |
| 2015 Q1 | 12.53 Million USD | 135.99% |
| 2014 Q4 | 5.31 Million USD | -49.42% |
| 2014 Q2 | 8.11 Million USD | 3.97% |
| 2014 FY | - USD | -28.07% |
| 2014 Q1 | 7.8 Million USD | -45.35% |
| 2014 Q3 | 10.5 Million USD | 29.5% |
| 2013 Q3 | 13.95 Million USD | 54.32% |
| 2013 Q4 | 14.27 Million USD | 2.32% |
| 2013 FY | - USD | 6.84% |
| 2013 Q1 | 12.9 Million USD | -5.83% |
| 2013 Q2 | 9.04 Million USD | -29.94% |
| 2012 Q2 | 4.57 Million USD | -37.52% |
| 2012 Q4 | 13.7 Million USD | 94.52% |
| 2012 Q1 | 7.32 Million USD | -73.65% |
| 2012 FY | - USD | -31.15% |
| 2012 Q3 | 7.04 Million USD | 53.92% |
| 2011 Q2 | 18.34 Million USD | 30.22% |
| 2011 Q3 | 12.62 Million USD | -31.18% |
| 2011 Q1 | 14.08 Million USD | 363.49% |
| 2011 Q4 | 27.79 Million USD | 120.18% |
| 2011 FY | - USD | 143.86% |
| 2010 Q2 | 17.07 Million USD | 1672.01% |
| 2010 FY | - USD | 88.64% |
| 2010 Q4 | -5.34 Million USD | -137.85% |
| 2010 Q1 | -1.08 Million USD | -240.31% |
| 2010 Q3 | 14.12 Million USD | -17.26% |
| 2009 Q3 | 6.66 Million USD | 28.49% |
| 2009 FY | - USD | -7.71% |
| 2009 Q4 | 774 Thousand USD | -88.38% |
| 2009 Q2 | 5.18 Million USD | -3.89% |
| 2009 Q1 | 5.39 Million USD | 106.12% |
| 2008 FY | - USD | 5.13% |
| 2008 Q4 | -88.17 Million USD | -2090.77% |
| 2008 Q1 | 1.73 Million USD | -62.44% |
| 2008 Q2 | 4.88 Million USD | 181.0% |
| 2008 Q3 | 4.42 Million USD | -9.26% |
| 2007 Q1 | 2.62 Million USD | 700.91% |
| 2007 FY | - USD | 402.43% |
| 2007 Q4 | 4.62 Million USD | -1.55% |
| 2007 Q3 | 4.69 Million USD | 17.6% |
| 2007 Q2 | 3.99 Million USD | 52.04% |
| 2006 Q1 | 1.31 Million USD | 146.12% |
| 2006 Q2 | -5.63 Million USD | -527.16% |
| 2006 Q3 | -1.25 Million USD | 77.73% |
| 2006 Q4 | 328 Thousand USD | 126.16% |
| 2006 FY | - USD | -150.43% |
| 2005 FY | - USD | -39.65% |
| 2005 Q1 | 4.8 Million USD | 50.31% |
| 2005 Q2 | 3.82 Million USD | -20.42% |
| 2005 Q3 | 5.22 Million USD | 36.65% |
| 2005 Q4 | -2.85 Million USD | -154.71% |
| 2004 Q2 | 4.73 Million USD | -5.79% |
| 2004 Q3 | 4.36 Million USD | -7.8% |
| 2004 Q4 | 3.19 Million USD | -26.76% |
| 2004 Q1 | 5.02 Million USD | 75.6% |
| 2004 FY | - USD | -17.95% |
| 2003 Q1 | 5.92 Million USD | 2.49% |
| 2003 Q4 | 2.86 Million USD | -19.45% |
| 2003 Q3 | 2.29 Million USD | -51.87% |
| 2003 Q2 | 6.07 Million USD | 0.92% |
| 2003 FY | - USD | -28.12% |
| 2002 Q3 | 7.28 Million USD | -6.11% |
| 2002 Q4 | 7.13 Million USD | -2.03% |
| 2002 Q2 | 7.75 Million USD | 7.95% |
| 2002 Q1 | 8.03 Million USD | 67.58% |
| 2002 FY | - USD | 53.95% |
| 2001 Q3 | 6.57 Million USD | -8.95% |
| 2001 Q4 | 4.28 Million USD | -15.56% |
| 2001 Q1 | 5.11 Million USD | 243.31% |
| 2001 Q2 | 5.57 Million USD | 35.04% |
| 2001 FY | - USD | 172.57% |
| 2000 Q2 | 1.78 Million USD | 34.77% |
| 2000 Q4 | 1.2 Million USD | 215.75% |
| 2000 Q3 | 381 Thousand USD | -78.68% |
| 2000 FY | - USD | -26.11% |
| 2000 Q1 | 2.55 Million USD | -8.68% |
| 1999 Q2 | 1.1 Million USD | 37.5% |
| 1999 Q4 | 1.45 Million USD | 81.5% |
| 1999 Q3 | 800 Thousand USD | -27.27% |
| 1999 Q1 | 1.01 Million USD | -86.21% |
| 1999 FY | - USD | -5.31% |
| 1998 Q4 | 2.4 Million USD | 205.26% |
| 1998 FY | - USD | 158.82% |
| 1998 Q1 | 1.5 Million USD | 107.94% |
| 1998 Q2 | 1.7 Million USD | 20.0% |
| 1998 Q3 | 2.3 Million USD | 58.33% |
| 1997 Q4 | -12 Million USD | -231.58% |
| 1997 Q3 | -3.2 Million USD | -850.0% |
| 1997 Q2 | 100 Thousand USD | -33.33% |
| 1997 Q1 | 300 Thousand USD | 96.3% |
| 1997 FY | - USD | 49.55% |
| 1996 FY | - USD | 0.0% |
| 1996 Q1 | 67.7 Million USD | 0.0% |
| 1996 Q4 | -7.4 Million USD | -1257.14% |
| 1996 Q3 | 1.1 Million USD | -98.97% |
| 1996 Q2 | 67.7 Million USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 189.11 Million USD | -99.242% |
| Addus HomeCare Corporation | 106.55 Million USD | -253.606% |
| AirSculpt Technologies, Inc. | 28.31 Million USD | -1230.867% |
| Amedisys, Inc. | 216.91 Million USD | -73.708% |
| American Oncology Network, Inc. | -39.35 Million USD | 1057.523% |
| Astrana Health, Inc. | 123.68 Million USD | -204.633% |
| Aveanna Healthcare Holdings Inc. | 44.34 Million USD | -749.632% |
| IMAC Holdings, Inc. | -5.94 Million USD | 6436.102% |
| biote Corp. | 9.23 Million USD | -3980.518% |
| Cryo-Cell International, Inc. | -10.41 Million USD | 3717.016% |
| Cross Country Healthcare, Inc. | 129.33 Million USD | -191.333% |
| COMPASS Pathways plc | -123.8 Million USD | 404.353% |
| DocGo Inc. | 32.72 Million USD | -1051.392% |
| The Ensign Group, Inc. | 353.23 Million USD | -6.669% |
| Healthcare Services Group, Inc. | 75.21 Million USD | -400.977% |
| InnovAge Holding Corp. | 1.15 Million USD | -32551.213% |
| Assure Holdings Corp. | -19.82 Million USD | 2000.701% |
| The Joint Corp. | 9.14 Million USD | -4021.708% |
| LifeStance Health Group, Inc. | -104.92 Million USD | 459.105% |
| Mobile-health Network Solutions Class A Ordinary Shares | -15.55 Million USD | 2522.392% |
| ModivCare Inc. | -26.75 Million USD | 1508.579% |
| NewGenIvf Group Limited | 384.3 Thousand USD | -97945.823% |
| Novo Integrated Sciences, Inc. | -5.84 Million USD | 6542.04% |
| P3 Health Partners Inc. | -81.07 Million USD | 564.772% |
| P3 Health Partners Inc. | -81.07 Million USD | 564.772% |
| The Pennant Group, Inc. | 30.36 Million USD | -1140.722% |
| Surgery Partners, Inc. | 446.1 Million USD | 15.536% |
| Syra Health Corp. Class A Common Stock | -2.83 Million USD | 13386.677% |
| Talkspace, Inc. | -22.01 Million USD | 1811.693% |
| Talkspace, Inc. | -22.01 Million USD | 1811.693% |
| The Oncology Institute, Inc. | -70.45 Million USD | 634.81% |
| The Oncology Institute, Inc. | -70.45 Million USD | 634.81% |